Keith Westby Iveric Bio, Inc. (ISEE) insider trading activity

Keith Westby is SVP, Chief Operating Officer of IVERIC bio, Inc.. Currently has a direct ownership of 0 shares of ISEE, which is worth approximately $0. The most recent transaction as insider was on Dec 13, 2022, when has been sold 6,741 shares (Common Stock) at a price of $21.73 per share, resulting in proceeds of $146,481. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Keith Westby Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 13 2022	SELL Open market or private sale	$146,481 $21.73 p/Share	6,741 Reduced 8.21%	75,324 Common Stock
Dec 12 2022	SELL Open market or private sale	$113,037 $20.96 p/Share	5,393 Reduced 7.19%	69,565 Common Stock
Dec 12 2022	BUY Exercise of conversion of derivative security	-	12,500 Added 13.22%	82,065 Common Stock
Dec 09 2022	BUY Exercise of conversion of derivative security	-	10,000 Added 11.77%	74,958 Common Stock
Dec 02 2022	BUY Exercise of conversion of derivative security	$52,145 $10.03 p/Share	5,199 Added 7.41%	64,958 Common Stock
Dec 01 2022	SELL Open market or private sale	$230,288 $22.96 p/Share	10,030 Reduced 14.37%	59,759 Common Stock
Nov 01 2022	SELL Open market or private sale	$1,744,150 $23.92 p/Share	72,916 Reduced 51.33%	69,128 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$62,228 $1.45 p/Share	42,916 Added 23.2%	142,044 Common Stock
Apr 18 2022	SELL Open market or private sale	$166,300 $16.63 p/Share	10,000 Reduced 9.16%	99,128 Common Stock
Apr 05 2022	SELL Open market or private sale	$176,848 $19.02 p/Share	9,298 Reduced 7.85%	109,128 Common Stock
Apr 05 2022	BUY Exercise of conversion of derivative security	$13,482 $1.45 p/Share	9,298 Added 7.28%	118,426 Common Stock
Apr 04 2022	SELL Open market or private sale	$393,338 $19.0 p/Share	20,702 Reduced 15.95%	109,128 Common Stock
Apr 04 2022	BUY Exercise of conversion of derivative security	$30,018 $1.45 p/Share	20,702 Added 13.75%	129,830 Common Stock
Mar 17 2022	SELL Open market or private sale	$32,274 $15.06 p/Share	2,143 Reduced 1.93%	109,128 Common Stock
Mar 16 2022	SELL Open market or private sale	$117,934 $15.01 p/Share	7,857 Reduced 6.6%	111,271 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$16,779 $1.65 p/Share	10,169 Added 7.91%	118,449 Common Stock
Feb 15 2022	SELL Open market or private sale	$151,600 $15.16 p/Share	10,000 Reduced 8.45%	108,280 Common Stock
Feb 07 2022	SELL Open market or private sale	$150,000 $15.0 p/Share	10,000 Reduced 7.8%	118,280 Common Stock
Jan 03 2022	SELL Open market or private sale	$201,236 $16.39 p/Share	12,278 Reduced 8.74%	128,280 Common Stock
Dec 31 2021	BUY Exercise of conversion of derivative security	-	32,500 Added 18.78%	140,558 Common Stock
Dec 21 2021	SELL Open market or private sale	$317,800 $15.89 p/Share	20,000 Reduced 15.62%	108,058 Common Stock
Dec 20 2021	SELL Open market or private sale	$69,727 $15.44 p/Share	4,516 Reduced 3.41%	128,058 Common Stock
Dec 18 2021	BUY Exercise of conversion of derivative security	-	12,500 Added 8.62%	132,574 Common Stock
Dec 13 2021	SELL Open market or private sale	$66,581 $14.74 p/Share	4,517 Reduced 3.63%	120,074 Common Stock
Dec 12 2021	BUY Exercise of conversion of derivative security	-	12,500 Added 9.12%	124,591 Common Stock

Keith Westby

SVP, Chief Operating Officer

Parsippany, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ISEE shares.

Notify only if

Value

Insider Trading

Get notified when an Iveric Bio, Inc. insider buys or sells ISEE shares.

Notify only if

Operation

Value

Type

News

Receive news related to IVERIC bio, Inc.

Track Activities on ISEE

Account